EUVIMEDOpdag EUVIMED
Beobachtungsstudie

A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations

Kazuto Hayasaka, Takeshi Sasaki iD, Yasuhiro Shirai iD, Hikaru Shimosato, Tomohiro Tahara, Shota Segami, Ryo Nagasawa, Ko Akimoto, Kento Yabe, Chisashi Toya, Keita Watanabe iD, Shu Yamashita and 6 more

Pacing and Clinical Electrophysiology · 2023-06 · 46 (6) · 475-486

DOI: 10.1111/pace.14709 ↗

At a glance

Beobachtungsstudie in Pacing and Clinical Electrophysiology, published online on 2023-05-02. Written by Kazuto Hayasaka and 17 co-authors. Institution: Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan. Major MEDLINE topics: Atrial Fibrillation, Pulmonary Veins, Cryosurgery, Catheter Ablation. Cited 3 times so far (Crossref); 18 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Backgrounds Catheter ablation for non‐paroxysmal atrial fibrillation (non‐PAF) remains challenging and more effective strategy has been required to reduce postoperative arrhythmia recurrences. This study aims to investigate the efficacy and safety of a novel extensive ablation strategy for non‐PAF, that is based on a combination of cryoballoon (CBA), radiofrequency (RFA), and Marshall‐vein ethanol ablations (EA‐VOM).

Methods

The study was a single‐center, retrospective observational study. We enrolled 171 consecutive patients who underwent de‐novo catheter ablation for non‐PAF under conscious sedation with a novel extensive ablation strategy that included CBA for pulmonary vein isolation (PVI) and left atrial roof ablation (LARA), RFA for mitral isthmus (MI) ablation, superior vena cava isolation, and other linear ablations and EA‐VOM. Recurrence of atrial arrhythmias over 1 year, procedure outcomes, and procedure‐related complications were investigated.

Results

A total of 139 (81.3%) patients remained in sinus rhythm during 1‐year follow‐up. Of the 139 patients, 51 patients (29.8%) received antiarrhythmic drugs. The mean procedure time was 204 ± 45 min. PVI and LARA ablation by CBA and MI block by RFA and EA‐VOM were completed in 171 (100%) and 166 (97.1%) patients, respectively. No serious procedure‐related complications were observed except for one case of delayed pericardial effusion.

Conclusion

Approximately 80% of the study patients were AF‐free during 1‐year follow‐up period after a single procedure based on the novel extensive ablation strategy combining CBA, RFA, and EA‐VOM. This strategy for non‐PAF may be preferred in terms of maintenance of sinus rhythm, safety even in high‐risk patients, and relatively short procedure time.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationPulmonary VeinsCryosurgeryCatheter AblationHumansEthanolVena Cava, SuperiorHeart AtriaTreatment OutcomeRecurrence

Author keywords

atrial fibrillationcatheter ablationcryoballoon ablationethanol ablationvein of Marshall

Substances

Ethanol

Authors and institutions

  • Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Department of Cardiology, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan.
  • Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

ORCID profiles: Takeshi Sasaki, Yasuhiro Shirai, Keita Watanabe, Kaoru Okishige

Cite

APA

Hayasaka, K., Sasaki, T., Shirai, Y., Shimosato, H., Tahara, T., Segami, S., Nagasawa, R., Akimoto, K., Yabe, K., Toya, C., Watanabe, K., Yamashita, S., Suzuki, M., Sugiyama, K., Yamauchi, Y., Okishige, K., Goya, M., & Sasano, T. (2023). A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations. Pacing and Clinical Electrophysiology, 46(6), 475-486. https://doi.org/10.1111/pace.14709

Vancouver

Hayasaka K, Sasaki T, Shirai Y, Shimosato H, Tahara T, Segami S, et al. A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations. Pacing and Clinical Electrophysiology. 2023;46(6):475-486. doi:10.1111/pace.14709

BibTeX
@article{Hayasaka2023,
  author = {Hayasaka, Kazuto and Sasaki, Takeshi and Shirai, Yasuhiro and Shimosato, Hikaru and Tahara, Tomohiro and Segami, Shota and Nagasawa, Ryo and Akimoto, Ko and Yabe, Kento and Toya, Chisashi and Watanabe, Keita and Yamashita, Shu and Suzuki, Masahito and Sugiyama, Koji and Yamauchi, Yasuteru and Okishige, Kaoru and Goya, Masahiko and Sasano, Tetsuo},
  title = {A novel catheter ablation strategy for non‐paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall‐vein ethanol ablations},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  volume = {46},
  number = {6},
  pages = {475--486},
  doi = {10.1111/pace.14709}
}
Start for free →